Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Takeuchi

Showing results (911-920 of 945) with videos related to

Pageof 95
Sort By:
Clinical Pharmacology and Therapeutics|January 20, 1998
Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacyT Hirano, K Oka, H Takeuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1997
[Plasma cell leukemia associated with monocytosis]K Yoshida, K Aida, T Horibe, et al.
Pharmacopsychiatry|October 28, 2015
Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic StudyT Tsuboi, R R Bies, T Suzuki, et al.
Anticancer Research|August 23, 2000
Vinca alkaloids induce granulocyte-macrophage colony stimulating factor in human peripheral blood mononuclear cellsK Ogura, S Ohta, T Ohmori, et al.
Endoscopy|September 26, 2001
Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitroS Ito, N Muguruma, Y Kusaka, et al.
Transplantation Proceedings|May 28, 2005
Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapyY Nakamura, H Takeuchi, K Okuyama, et al.
Transplantation Proceedings|May 28, 2005
Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapyT Iwahori, H Takeuchi, N Matsuno, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 1998
[Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid]K Itoh, W Gotoh, F Yagasaki, et al.
Transplantation Proceedings|May 28, 2005
Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parametersH Takeuchi, K Okuyama, O Konno, et al.
Cancer Chemotherapy and Pharmacology|April 14, 2016
A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumorsK Watanabe, S Otsu, Y Hirashima, et al.
Pageof 95

Showing results (911-920 of 945) with videos related to

Sort By:
Pageof 95
Clinical Pharmacology and Therapeutics|January 20, 1998
Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacyT Hirano, K Oka, H Takeuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1997
[Plasma cell leukemia associated with monocytosis]K Yoshida, K Aida, T Horibe, et al.
Pharmacopsychiatry|October 28, 2015
Predicting Plasma Olanzapine Concentration Following a Change in Dosage: A Population Pharmacokinetic StudyT Tsuboi, R R Bies, T Suzuki, et al.
Anticancer Research|August 23, 2000
Vinca alkaloids induce granulocyte-macrophage colony stimulating factor in human peripheral blood mononuclear cellsK Ogura, S Ohta, T Ohmori, et al.
Endoscopy|September 26, 2001
Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitroS Ito, N Muguruma, Y Kusaka, et al.
Transplantation Proceedings|May 28, 2005
Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapyY Nakamura, H Takeuchi, K Okuyama, et al.
Transplantation Proceedings|May 28, 2005
Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapyT Iwahori, H Takeuchi, N Matsuno, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 1998
[Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid]K Itoh, W Gotoh, F Yagasaki, et al.
Transplantation Proceedings|May 28, 2005
Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parametersH Takeuchi, K Okuyama, O Konno, et al.
Cancer Chemotherapy and Pharmacology|April 14, 2016
A phase I study of binimetinib (MEK162) in Japanese patients with advanced solid tumorsK Watanabe, S Otsu, Y Hirashima, et al.
Pageof 95